Company

Karus Therapeutics

As of the edition of 20 October 2026, Karus Therapeutics runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Went quiet1
Stopped1
Total2

Where its trials are

  • Cancer: 2 trials led
  • Blood and lymph: 1 trials led
  • Digestive system: 1 trials led